We are elated to announce that Healx, an AI-powered technology company that shares our passion for patient-centered care, has chosen to team up with Mission: Cure to help find a cure for chronic pancreatitis! Mission: Cure was chosen from among many rare disease organizations to be part of Healx’s Rare Treatment Accelerator Program (RTA) with the aim of starting a clinical trial and eventually develop a treatment for pancreatitis.
Launched in October 2019, Healx’s Rare Treatment Accelerator program uses artificial intelligence, drug development, and clinical trial expertise to evaluate, enhance, and accelerate repurposed drugs to treat rare diseases. Healx will devote significant financial resources to the effort, with the aim of starting a clinical trial for a chronic pancreatitis therapy within 12 months. Mission: Cure will provide insights into patient needs and connections to pancreatitis experts.
This innovative partnership will bring chronic pancreatitis patients closer to a treatment for this terrible disease. We are excited to move the needle forward for pancreatitis patients with the help of Healx.
”Recognising the all-too-common lack of financial investment and clinical expertise needed to translate repurposed drugs from research to reality, Healx will use its AI, drug development and clinical expertise, as well as significant financial resources, to evaluate, enhance and accelerate the repurposed drugs, with the aim of starting a clinical trial within 6-12 months.Healx Press Release
Join Our Newsletter to Receive Updates on the Rare Treatment Accelerator
Healx was founded in 2014 in Cambridge, UK, by Dr Tim Guilliams, a Biochemical Engineer and Tech Entrepreneur, and Dr David Brown, co-inventor of Viagra and former Global Head of Drug Discovery at Roche.
Healx is an AI-powered, patient-inspired technology company, accelerating the discovery and development of rare disease treatments at scale. There are 7,000 known rare diseases that affect 400 million people across the globe but only 5% of those conditions have approved treatments. Healx’s mission is to identify and progress novel therapies for the 95% of rare diseases without approved treatment. To do this, Healx combines AI technology with drug discovery expertise and patient insight to identify existing drugs that may be repurposed and combined to treat rare diseases.
About Mission: Cure
Mission: Cure is a nonprofit organization that aims to dramatically improve the health and well-being of people suffering from chronic and recurrent acute pancreatitis within 10 years, demonstrating a new model for curing disease. Mission: Cure partners with patients and their families, researchers, clinicians, pharmaceutical companies, and other stakeholders to discover life-altering therapies—including repurposed drugs—and bring them to patients. To support efficient therapy development and more effective care pathways, Mission: Cure works with health systems and payers to pilot innovative funding models that incentivize patient outcomes.